Browsing Tag
Corcept Therapeutics
2 posts
Why did the FDA double down on rejecting Corcept’s flagship drug? Investors rattled
Corcept Therapeutics faces fresh regulatory headwinds as the FDA revises its relacorilant rejection letter, highlighting safety concerns and strategic missteps. Read more.
Corcept Therapeutics submits FDA application for relacorilant to treat Cushing’s syndrome
Corcept Therapeutics Incorporated has taken a significant step in addressing the unmet needs of patients with hypercortisolism, commonly…